Atul Butte

Atul Butte studied computer science at Brown University, then worked as a software engineer at Apple and Microsoft. He received his medical degree from Brown University and trained in pediatrics and pediatric endocrinology at Children’s Hospital Boston. He received his Ph.D. from Harvard Medical School and MIT. Butte has authored nearly 200 peer-reviewed publications, and his research is frequently featured in Wired, The New York Times, and The Wall Street Journal. In 2013, Butte was recognized by the White House as an Open Science Champion of Change for promoting the advancement of science through the use of publicly available data. Butte is a founder of three investor-backed data-driven companies: Personalis, which provides clinical interpretation of whole genome sequences; Carmenta (acquired by Progenity), which is discovering diagnostics for complications of pregnancy; and NuMedii, which is finding new uses for drugs through open molecular data. Butte is also principal investigator of ImmPort, the clinical and molecular data repository for the National Institute of Allergy and Infectious Diseases.